French food giant Danone has reportedly raised its offer for the infant nutrition business of US pharmaceutical group Pfizer.

The bid, according to news website WanSquare, is close to US$11bn in an attempt to outbid rival Nestle, the publication has said.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Reports this week have suggested that Pfizer is nearing a deal to sell its infant nutrition unit for $9-10bn, with European food major Nestle also cited as a potential buyer.

Pfizer has insisted it will get maximum value for its shareholders out of any move to separate its infant nutrition business.

Just Food Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Just Food Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving food industry advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now